Overture Life
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
2479 E Bayshore Rd, Palo Alto, Californi...Website
overture.lifeRevenue
$11.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
2
1
1
About Overture Life
Overture Life integrates engineering, reproductive medicine, and regulatory-grade validation to modernize embryology lab procedures, particularly egg freezing and embryo handling, in ways that lower repeated cycles, increase throughput, and reduce the overall cost of IVF. With R&D in Spain and active U.S. operations, including a CLIA-licensed laboratory for non-invasive embryo selection, Overture unites robotics, analytics, and clinical rigor to deliver tools that clinics and patients can trust. The companys DaVitri platform aims to boost reliability and consistency in IVF, giving women and families worldwide more control over their fertility timelines. Overtures backers include Overwater Ventures, GV, Khosla Ventures, Octopus Ventures and others committed to advancing the future of fertility.Explore more
Overture Life Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Overture Life your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Overture Life has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Overture Life launches new products
Funding: Get notified immidiatlly once Overture Life has new funding data
Click to see if Overture Life had a recent Job posting/layoffs
Earning: See what the market has to say on Overture Life recently announced quarterly report
Check out if Overture Life is spiking on competitors!
Overture Life, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Overture Life
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Overture Life
Find 3 more new buyers
Compare Similar Companies to Overture Life
Compare insights from companies similar to Overture Life, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Overture Life is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Overture Life is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Overture Life.
Overture Life financials insights
Gather financial insights about Overture Life, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Series A
$20M
2021
Series B
$15M
2025
Other Financing Round
$20.6M
Overture Life Tech Stack
A closer look at the technologies used by Overture Life
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
New Hire
Executive Move
Executive Moves, New Hire
Award
Award, Healthcare Technology
Funding
Funding
New Hire
Executive Move
Overture Life News & Media
Overture Life Appoints Former Butterfly Network Executive Matt Combs as Chief Commercial Officer to Lead Scale-up of IVF Automation Technology as Demand Surges Worldwide
PALO ALTO, Calif.--(BUSINESS WIRE)--Overture Life, the leader in automated IVF technology that delivered the first live births in the world from automated fertilization and egg freezing, today announced the appointment of Matthew Combs as Chief Commercial Officer (CCO). Combs joins Overture to drive global expansion amid rising domestic and international demand for IVF automation technology that directly addresses the embryologist shortages worldwide. In the newly created role, Combs will leadOverture Life Secures $57M in Total Funding and Earns U.S. CLIA License to Deliver ...
Overture Life today announced a $20.6 million strategic round, bringing its total funding to $57 million from leading industry investors, to support addition...Overture Life Initiates Trial of Non-Invasive Embryo Selection Testing
NEW YORK, Oct. 26, 2021 /PRNewswire/ -- Overture Life, a clinical-stage biotechnology company whose mission is to automate assisted reproductive processes and offer non-invasive embryo selection to improve in-vitro fertilization (IVF) pregnancy outcomes, today announced it has launched a...Overture Life Raises $15M in Series B Funding from Octopus Ventures...
The round brings the company’s total fundraising to $37M (PRWeb May 26, 2021) Read the full story at https://www.prweb.com/releases/overture_life_raises_15m_in_series_b_funding_from_octopus_ventures_with_participation_from_gv_and_existing_investors/prweb17960409.htm
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Overture Life
Sign Up For FreeTo access detailed company insights
Overture Life integrates engineering, reproductive medicine, and regulatory-grade validation to modernize embryology lab procedures, particularly egg freezing and embryo handling, in ways that lower repeated cycles, increase throughput, and reduce the overall cost of IVF. With R&D in Spain and active U.S. operations, including a CLIA-licensed labor... Read More
